Online citations, reference lists, and bibliographies.

Improved Survival In Rectal Cancer Patients Who Are Treated With Long‐course Versus Short‐course Neoadjuvant Radiotherapy: A Propensity‐matched Analysis Of The NCDB

B. Chapman, Karyn A. Goodman, P. Hosokawa, A. Gleisner, Michelle L. Cowan, E. Birnbaum, J. Vogel
Published 2019 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Randomized controlled trials have demonstrated comparable survival outcomes for short-course (SCRT) and long-course neoadjuvant radiotherapy (LCRT) in patients with rectal cancer. METHODS Using the National Cancer Data Base (2004-2015), a propensity score was used to match 188 patients with rectal cancer receiving SCRT to 376 patients receiving LCRT. Perioperative, oncologic, and survival outcomes were compared. RESULTS Patient and clinical tumor characteristics were similar between groups. Patients in the LCRT were more likely to undergo surgery (91% vs 85%; P = 0.03). The LCRT group were more likely to have tumor (T) (56% vs 43%) and nodal (N) (25% vs 19%) downstaging, and a complete pathological response (15% vs 6%) compared with the SCRT group (all P < 0.05). Length of stay (6 vs 8 days), 30-day (1% vs 5%) mortality, and 90-day mortality (1% vs 10%) were significantly lower in the LCRT group (all P < 0.05). After adjusting for patient and tumor-related characteristics, LCRT was associated with a 50% reduction in the risk of mortality compared with SCRT (hazard ratios, 0.50; 95% confidence interval, 0.35-0.70). CONCLUSIONS In this analysis, LCRT was superior to SCRT in terms of tumor response to neoadjuvant therapy, perioperative mortality, and overall survival. These findings provide evidence for the use of LCRT when neoadjuvant therapy is indicated.
This paper references
10.1002/sim.6004
A comparison of 12 algorithms for matching on the propensity score
P. Austin (2014)
10.1097/01.sla.0000231797.37743.9f
Reoperation as a Quality Indicator in Colorectal Surgery: A Population-Based Analysis
A. Morris (2007)
10.1016/j.clon.2016.02.002
Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service
E. Morris (2016)
10.1016/0895-4356(92)90133-8
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.
R. Deyo (1992)
10.1200/JCO.2011.40.1836
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.
R. Sauer (2011)
10.1056/NEJMOA040694
Preoperative versus postoperative chemoradiotherapy for rectal cancer.
R. Sauer (2004)
10.1200/JCO.2013.54.3769
Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.
E. Fokas (2014)
10.1097/SLA.0b013e3182a18fcc
Assessing Readmission After General, Vascular, and Thoracic Surgery Using ACS-NSQIP
Donald J. Lucas (2013)
10.1016/j.suronc.2014.10.003
Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.
Zhi-rui Zhou (2014)
10.1111/j.1463-1318.2005.00796.x
Postoperative complications in patients irradiated pre‐operatively for rectal cancer: report of a randomised trial comparing short‐term radiotherapy vs chemoradiation
K. Bujko (2005)
10.1016/0021-9681(87)90171-8
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
M. Charlson (1987)
10.1016/j.jamcollsurg.2012.05.024
Risk factors for 30-day hospital readmission among general surgery patients.
Michael T. Kassin (2012)
10.1245/s10434-016-5508-5
Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER–Medicare Database
Chun Chieh Lin (2016)
10.1097/00042737-200110000-00028
[Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer].
U. Tiefenbacher (2001)
10.1016/S1470-2045(17)30086-4
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
J. Erlandsson (2017)
2018 Cancer facts & figures
R Sauer
10.1001/jamaoncol.2016.6905
Using the National Cancer Database for Outcomes Research: A Review
D. Boffa (2017)
10.1200/JCO.2004.05.063
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
A. Benson (2004)
10.1200/JCO.2012.42.9597
Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
S. Ngan (2012)
10.1016/S0140-6736(09)60484-0
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
D. Sebag-Montefiore (2009)
10.1200/JCO.2009.22.0467
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.
M. Roh (2009)
10.1093/ANNONC/MDS236
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.
H. Schmoll (2012)
10.1016/S1470-2045(11)70097-3
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.
W. van Gijn (2011)
10.1002/bjs.8702
Systematic review and meta‐analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer
S. Martin (2012)
10.1016/j.prro.2015.11.014
Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Appropriateness Method.
K. Goodman (2016)
10.1111/j.1463-1318.2011.02815.x
Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short‐course radiotherapy or long‐term chemoradiotherapy, both with delayed surgery
T. Latkauskas (2012)
10.1002/bjs.5506
Long‐term results of a randomized trial comparing preoperative short‐course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
K. Bujko (2006)
10.1200/JCO.2011.39.7901
Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.
I. Park (2012)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar